Financhill
Back

AtkinsRéalis Group, Inc. Vs. Insmed, Inc. Industry Stock Comparison

Buy
58

SNCAF
AtkinsRéalis Group, Inc.

Last Price:
$63.27
Seasonality Move:
6.49%
Sell
40

INSM
Insmed, Inc.

Last Price:
$174.52
Seasonality Move:
7.61%
Buy
58
AtkinsRéalis Group, Inc. (SNCAF) is a Buy

Is AtkinsRéalis Group, Inc. a Buy, Sell or Hold?

  • The current AtkinsRéalis Group, Inc. [SNCAF] share price is $62.36. The Score for SNCAF is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • SNCAF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Insmed, Inc. (INSM) is a Sell

Is Insmed, Inc. a Buy, Sell or Hold?

  • The current Insmed, Inc. [INSM] share price is $166.55. The Score for INSM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • INSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SNCAF Stock Price Chart

What is AtkinsRéalis Group, Inc.'s stock price today?

  • The AtkinsRéalis Group, Inc. share price today is $62.36
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNCAF is experiencing buying pressure, which is a positive indicator for future bullish movement.

INSM Stock Price Chart

What is Insmed, Inc.'s stock price today?

  • The Insmed, Inc. share price today is $166.55
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INSM is experiencing slight selling pressure.

SNCAF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.78 Buy
Relative Strength Index (14 RSI): 44.1 Sell
Chaikin Money Flow: 532 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (61.38 - 64.1) Sell
Bollinger Bands (100): (64.19 - 72.21) Sell

INSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 29.93 Sell
Chaikin Money Flow: -270452 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (190.54 - 208.08) Sell
Bollinger Bands (100): (130.7 - 191.18) Buy

SNCAF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.13 Sell
20-day SMA: 62.55 Sell
50-day SMA: 65.83 Sell
200-day SMA: 63.48 Sell
8-day EMA: 24.52 Buy
20-day EMA: 11.26 Buy
50-day EMA: 4.77 Buy
200-day EMA: 1.23 Buy

INSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 192.36 Sell
20-day SMA: 199.79 Sell
50-day SMA: 186.64 Sell
200-day SMA: 121.17 Buy
8-day EMA: 191.25 Sell
20-day EMA: 194.86 Sell
50-day EMA: 184.92 Sell
200-day EMA: 135.61 Buy

AtkinsRéalis Group, Inc. Earnings Growth & SNCAF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Insmed, Inc. Earnings Growth & INSM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.77 per share, and an increase next year of $2.60 per share.

AtkinsRéalis Group, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Insmed, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):